Not a good buy right now for an impatient trader: the stock is deeply oversold, but the broader trend is still bearish and there are no Intellectia entry signals to justify forcing an immediate entry.
Best near-term setup is only a speculative oversold bounce trade off support (~7.41 / ~7.04). Without a clear reversal, risk is that support breaks and downside accelerates.
Options flow is conflicted (call-heavy open interest but put-heavy volume today), which reinforces “wait for confirmation” rather than chasing pre-market.
Upcoming earnings (2026-02-19 after hours) is the next major catalyst; direction could swing sharply, making “buy right now” less attractive absent confirmation.
Momentum: RSI(6) = 19.53 (extremely oversold). This often precedes short bounces, but by itself does not confirm a trend reversal.
MACD: Histogram at -0.15 (below 0) but negatively contracting, suggesting downside momentum is easing, not yet turning positive.
Key levels vs pre-market (~7.54):
Support: S1 7.412 (very close), then S2 7.037 (next major downside level).
Resistance/Pivot: Pivot 8.018, then R1 8.625.
Practical read: Price is sitting just above first support—technically this is “bounce-or-break” territory. A clean reclaim of ~8.02 would improve the buy case; failing that keeps the downtrend intact.
Volatility: 30D IV 75.62 vs historical volatility 34.26 (IV far above realized) → market pricing large moves (often around catalysts like earnings).
Positioning/Sentiment:
Open interest put/call = 0.09 (call OI dominant) → longer-dated positioning looks more bullish/less hedged.
Put/call volume = 3.0 (puts dominant today) with volume 24.62x 30-day average → near-term tape is cautious/bearish (could be protection or directional puts).
Takeaway: Mixed signals—structural positioning leans bullish, but today’s flow leans defensive; not a clean “options-confirmed buy.”
Technical Summary
Sell
10
Buy
3
Positive Catalysts
Launch of VIPER Early Access Program using AI-powered imaging to improve appraisals and dealer transaction efficiency—supports narrative of tech-driven differentiation.
Neutral/Negative Catalysts
Dominant risk right now is technical: strong downtrend (bearish MA stack). Oversold can stay oversold; a break below ~7.41 / ~7.04 could trigger another leg down.
Options near-term fear: put-heavy volume spike today suggests traders are actively hedging or leaning bearish in the short run.
Earnings catalyst ahead: Q4/Dec 2025 earnings on 2026-02-19 after hours—high IV indicates the market expects a sizable move; a miss/weak outlook could pressure shares.
Sector/commentary headwinds: Analysts have cited “soft” auto unit pressures and concerns around incremental investments limiting margin expansion.
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: $199.56M, +16.48% YoY (solid growth, indicates continued marketplace/activity expansion).
Profitability trend: Net income -$24.47M, improved 52.63% YoY (losses narrowing meaningfully).
EPS: -$0.14, improved 40.0% YoY (trend improving, still negative).
Gross margin: 47.92%, +2.15% YoY (margin expansion is a constructive signal for operating leverage over time).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent rating/target trend is mixed-to-cautious:
Barclays (2026-01-21): PT raised to $8 from $7, Equal Weight (incrementally more positive on value but still neutral stance).
Jefferies (2025-12-11): Downgrade to Hold from Buy, PT $9 (concerns: slowing share gains, investment drag on margins, AI disintermediation risk).
Citi (2025-11-21): PT cut to $13 from $17 but kept Buy (sees 2026 product pipeline as a growth driver; viewed the post-earnings drop as opportunity).
Wall Street “pros” view:
Improving fundamentals (growth + narrowing losses), product pipeline, and used vehicle market momentum.
Wall Street “cons” view:
Slowing share gains, margin expansion uncertainty due to investments, and the stock’s weak price trend.
Influential/political trading check:
Congress trading (last 90 days): no data/none reported.
Hedge funds/insiders: neutral with no significant recent trend.
Wall Street analysts forecast ACVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACVA is 11.32 USD with a low forecast of 6 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
Wall Street analysts forecast ACVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACVA is 11.32 USD with a low forecast of 6 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
3 Hold
1 Sell
Moderate Buy
Current: 7.050
Low
6
Averages
11.32
High
20
Current: 7.050
Low
6
Averages
11.32
High
20
Barclays
Equal Weight
maintain
$7 -> $8
AI Analysis
2026-01-21
Reason
Barclays
Price Target
$7 -> $8
AI Analysis
2026-01-21
maintain
Equal Weight
Reason
Barclays raised the firm's price target on ACV Auctions to $8 from $7 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the auto retail group as part of its Q4 outlook. It broadly lowered estimates across the sector on "soft" auto sales unit pressures. However, trade checks suggest the used vehicle market has good momentum, the analyst tells investors in a research note.
Jefferies
John Colantuoni
Buy -> Hold
downgrade
$9
2025-12-11
Reason
Jefferies
John Colantuoni
Price Target
$9
2025-12-11
downgrade
Buy -> Hold
Reason
Jefferies analyst John Colantuoni downgraded ACV Auctions to Hold from Buy with an unchanged price target of $9. The firm recommends staying selective across the internet sector in 2026. Incremental investments could limit margin expansion and concerns around artificial intelligence disintermediation could limit multiple appreciation, the analyst tells investors in a research note. Jefferies cites ACV's slowing market share gains for the downgrade.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ACVA